SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending
10 references·0 citing·41 second hop
Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending (2006)Extensions Of Intellectual Property Right…University-Based Science and Biotechnology Products (2005)University-Based Science and …Powerful medicines: the benefits, risks, and costs of prescription drugs (2005)Powerful medicines: the benef…Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)Potential Savings from Substi…Generic Drug Industry Dynamics (2005)Generic Drug Industry DynamicsMedicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors (2004)Medicaid Prior-Authorization …The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending (2003)The Effect of Incentive-Based…Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans (2003)Economic Consequences of Unde…Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors (2002)Outcomes of Reference Pricing…A physician survey on generic drugs and substitution of critical dose medications (1997)A physician survey on generic…A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications (1997)A Physician Survey on Generic…The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)Users' Guides to the Medical Literature (1999)Sources of Regional Variation in Medicare Part D Drug Spending (2012)Geographic Variation in Expenditures for Physicians' Services in the United States (1993)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization? (2009)State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid (2010)Measuring the Scope of Prior Authorization Policies (2021)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting (2000)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Medical-Process Patents — Monopolizing the Delivery of Health Care (2006)Using Market-Exclusivity Incentives to Promote Pharmaceutical Innovation (2010)The valorization of non-patent intellectual property in academic medical centers (2020)Estimating Nonresponse Bias in Mail Surveys (1977)What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The effects of prescription drug cost sharing: a review of the evidence. (2005)The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2010)Payment Restrictions for Prescription Drugs under Medicaid (1987)METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Proposal of the Physicians' Working Group for Single-Payer National Health Insurance (2003)Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid (2004)The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use (2013)The Medical Expenditure Panel Survey: a national health information resource. (1997)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)Patients’ Perceptions Of Generic Medications (2009)Physician Perceptions About Generic Drugs (2011)Industry Structure, Market Rivalry, and Public Policy (1973)Specification Tests in Econometrics (1978)The price of innovation: new estimates of drug development costs (2003)Generic competition and market exclusivity periods in pharmaceuticals (2007)Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration (2010)Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011)The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions? (2012)Small fish, big fish: The performance effects of the relative standing in partners' affiliate portfolios (2014)Exploring Generic Drug Use Behavior (2002)
this work references cited by second hop

References

  • 2003The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending334 cited
  • 2005Generic Drug Industry Dynamics312 cited
  • 2005Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000271 cited
  • 2005Powerful medicines: the benefits, risks, and costs of prescription drugs191 cited
  • 2002Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors178 cited
  • 2004Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors111 cited
  • 1997A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications104 cited
  • 1997A physician survey on generic drugs and substitution of critical dose medications100 cited
  • 2003Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans72 cited
  • 2005University-Based Science and Biotechnology Products37 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work